Cryptocurrency Litecoin Up More Than 6% In 24 hours

Over the past 24 hours, Litecoin's (CRYPTO: LTC) price has risen 6.01% to $71.96. This continues its positive trend over the past week where it has experienced a 8.0% gain, moving from $66.43 to its current price. As it stands right now, the coin's all-time high is $410.26.

Over the past 24 hours, Litecoin’s (CRYPTO: LTC) price has risen 6.01% to $71.96. This continues its positive trend over the past week where it has experienced a 8.0% gain, moving from $66.43 to its current price. As it stands right now, the coin’s all-time high is $410.26.

The chart below compares the price movement and volatility for Litecoin over the past 24 hours (left) to its price movement over the past week (right). The gray bands are Bollinger Bands, measuring the volatility for both the daily and weekly price movements. The wider the bands are, or the larger the gray area is at any given moment, the larger the volatility.

price_chart

The trading volume for the coin has increased 74.0% over the past week while the overall circulating supply of the coin has increased 0.12% to over 74.08 million which makes up an estimated 88.19% of its max supply, which is 84.00 million. The current market cap ranking for LTC is #21 at $5.30 billion.

supply_and_vol

Powered by CoinGecko API

This article was generated by Benzinga’s automated content engine and reviewed by an editor.

Total
0
Shares
Related Posts
Read More

AstraZeneca Announced Enhertu approved in the EU as the first HER2-directed therapy for patients with HER2-low metastatic breast cancer

AstraZeneca and Daiichi Sankyo's Enhertu (trastuzumab deruxtecan) has been approved in the European Union (EU) as monotherapy for the treatment of adult patients with unresectable or metastatic HER2-low (IHC 1+ or IHC 2+/ISH-) breast cancer who have received prior chemotherapy in the metastatic setting or developed disease recurrence during or within six months of completing adjuvant chemotherapy.

AZN